Related Experiment Videos

Low-dose anticoagulation in Chinese patients with mechanical heart valves

Xin-Min Zhou1, Wei Zhuang, Jian-Guo Hu

  • 1Department of Cardiovascular Surgery, The Second Xiang-Ya Hospital of Central South University, Changsha, Hunan 410011, China. Mark037100@163.com

Asian Cardiovascular & Thoracic Annals
|November 24, 2005
PubMed

Insights

Optimal anticoagulation for Chinese patients with mechanical heart valves involves a lower target International Normalized Ratio (INR) of 1.4-2.0. This approach minimizes bleeding complications while effectively preventing thromboembolism, especially during the critical first postoperative month.

Area of Science:

  • Cardiology
  • Biomaterials Science
  • Clinical Pharmacology

Background:

  • Mechanical heart valve replacement is a critical procedure requiring careful anticoagulation management.
  • Optimizing anticoagulant therapy is essential to balance the risks of bleeding and thromboembolism.
  • Previous guidelines may not fully address the specific needs of Chinese patient populations.

Purpose of the Study:

  • To establish optimal anticoagulation guidelines for Chinese patients undergoing mechanical heart valve replacement.
  • To analyze the incidence of bleeding and thromboembolic events in relation to anticoagulation levels.
  • To identify critical periods for monitoring anticoagulation post-surgery.

Main Methods:

  • A retrospective study of 178 Chinese patients who received Carbomedics mechanical heart valves between July 2000 and July 2003.
  • Monitoring of International Normalized Ratio (INR) levels throughout the follow-up period.
  • Calculation of linearized rates for bleeding, thromboembolism, and mortality.

Main Results:

  • The study observed 22 bleeding events and 1 thromboembolic complication, with linearized rates of 5.83% and 0.26% per patient-year, respectively.
  • Bleeding was identified as the predominant complication in this cohort, rather than thromboembolism.
  • A mean final INR of 1.68+/-0.38 was recorded, with significant early-late follow-up variation; INR was most unstable in the first postoperative month.

Conclusions:

  • Low-dose anticoagulation, targeting an International Normalized Ratio (INR) of 1.4-2.0, is recommended for Chinese patients with mechanical heart valves.
  • This adjusted anticoagulation strategy can significantly reduce bleeding events while maintaining effective thromboembolism prevention.
  • Intensified patient monitoring during the first postoperative month is crucial due to INR instability to ensure optimal outcomes.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...